Join a global symposium exploring Hemophilia and Antiphospholipid Syndrome (APS) with patient stories and expert insights for ...

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have uncovered biological differences in how multiple myeloma develops and progresses in men and in women. The ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for side effects. Now new research by Fox Chase Cancer Center physicians shows ...

Prolytix, a U.S.-based bioanalytical leader, has acquired 60 validated thrombosis and hemostasis assays from Hemostasis Reference Laboratory (HRL).

Congenital factor VII deficiency is a rare, autosomal recessive disorder with an estimated prevalence of 1 in 1,000,000. We ...